Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis

E. Tabata (Yokohama, Japan), T. Takemura (Tokyo, Japan), T. Baba (Yokohama, Japan), E. Hagiwara (Yokohama, Japan), H. Nakagawa (Yokohama, Japan), T. Katano (Yokohama, Japan), G. Matama (Yokohama, Japan), N. Aiko (Yokohama, Japan), K. Isomoto (Yokohama, Japan), R. Ohtoshi (Yokohama, Japan), R. Shintani (Yokohama, Japan), S. Sadoyama (Yokohama, Japan), S. Ikeda (Yokohama, Japan), H. Yamakawa (Yokohama, Japan), T. Niwa (Yokohama, Japan), T. Oda (Yokohama, Japan), R. Okuda (Yokohama, Japan), A. Sekine (Yokohama, Japan), H. Kitamura (Yokohama, Japan), S. Komatsu (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Ogura (Yokohama, Japan)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Session: CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Session type: Oral Presentation
Number: 3820
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Tabata (Yokohama, Japan), T. Takemura (Tokyo, Japan), T. Baba (Yokohama, Japan), E. Hagiwara (Yokohama, Japan), H. Nakagawa (Yokohama, Japan), T. Katano (Yokohama, Japan), G. Matama (Yokohama, Japan), N. Aiko (Yokohama, Japan), K. Isomoto (Yokohama, Japan), R. Ohtoshi (Yokohama, Japan), R. Shintani (Yokohama, Japan), S. Sadoyama (Yokohama, Japan), S. Ikeda (Yokohama, Japan), H. Yamakawa (Yokohama, Japan), T. Niwa (Yokohama, Japan), T. Oda (Yokohama, Japan), R. Okuda (Yokohama, Japan), A. Sekine (Yokohama, Japan), H. Kitamura (Yokohama, Japan), S. Komatsu (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Ogura (Yokohama, Japan). Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis. 3820

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis
Source: Eur Respir J 2011; 37: 1503-1513
Year: 2011



Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Differences between ANCA positive and negative lung fibrosis cases without vasculitis
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019


Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF)
Source: Eur Respir J 2007; 30: Suppl. 51, 648s
Year: 2007

Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019
Year: 2020



Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF)
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004

Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis
Source: Eur Respir J 2009; 34: 1079-1085
Year: 2009



Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


Interstitial lung disease associated with ANCA positivity: a retrospective analysis
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease: CT and pathological findings in 62 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 488s
Year: 2004

p-ANCA positive Hashimoto‘s thyroiditis with interstitial pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 83s
Year: 2005

Clinical significance of histological UIP pattern in interstitial pneumonia with autoimmune features (IPAF)
Source: International Congress 2017 – Novel and old entities
Year: 2017


Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 267s
Year: 2002

Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Usefulness of surgical lung biopsies after cryobiopsies when pathological results are unspecific or show a pattern suggestive of a nonspecific interstitial pneumonia
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018



Myositis-specific antibodies in a cohort of idiopathic interstitial pneumonias with suggestive morphologies.
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018




Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002